GLP-1 side effects and 'Ozempic face': separating TikTok from trials

What did @myrajoinmochi actually say?

The creator walked viewers through what to do after a missed weekly Ozempic or Wegovy dose, citing what they described as FDA guidance. Their rule: if it has been less than five days, go ahead and inject. If it has been over five days, skip it and wait for your next scheduled dose. They tied this advice to semaglutide's half-life, saying "about 50% of that last dose medication is still in your system" for roughly a week after injection.

This is actually a fairly common piece of information that circulates in GLP-1 communities online, and in this case, the creator is largely repeating what is printed in Ozempic's prescribing information. That context matters, because not all TikTok health advice starts from a real document.

Does the science back this up?

Yes, the core pharmacokinetic claim is solid. Semaglutide has a well-established elimination half-life of approximately 7 days, which is why it works as a once-weekly injection. This means that one week after a dose, roughly half of the drug is still active in circulation.

The Ozempic U.S. prescribing label explicitly states the five-day missed-dose window: if a dose is missed, it can be administered within 5 days. If more than 5 days have passed, skip it and resume the next weekly dose on the regular schedule. The creator's description of this aligns with the label. Research published by Marbury et al. (2011, Clinical Pharmacokinetics) confirmed semaglutide's long half-life in early pharmacokinetic modeling, and this has been reproduced in multiple regulatory submissions. The half-life figure is not in dispute.

What did they get wrong (or right)?

Mostly right, with one small slip. The creator mispronounced both brand names, calling Ozempic "olympic" and Wegovy "wickety," which is trivial but worth noting for accuracy. More substantively, they said this guidance was found "both on the access FDA on Ozempic," which is garbled phrasing. The guidance appears in the Ozempic prescribing information, and the FDA does publish labeling documents, but the framing was unclear enough to potentially confuse viewers about where to look.

One thing they got genuinely right: they did not tell viewers to double-dose to make up for a missed injection. That is a common and dangerous misconception with weekly injectables, and the creator correctly advised against it by omission. The half-life explanation, while simplified, is scientifically reasonable and gives viewers a logical reason to trust the advice rather than just follow it blindly. That is actually better health communication than most TikTok content in this category.

What should you actually know?

The five-day rule applies to semaglutide products specifically, Ozempic and Wegovy. It does not automatically apply to tirzepatide (Mounjaro, Zepbound), which has its own prescribing guidance and a different pharmacokinetic profile, with a half-life of approximately 5 days. The creator did not mention tirzepatide by name, but viewers mixing up their medications could make a wrong assumption.

Also worth knowing: the five-day window counts from your scheduled injection day, not from when you remembered you missed it. If your regular dose day is Monday and you remember on Saturday, that is five days, and the decision point is right at the edge. When in doubt, contact your prescriber. Missed dose protocols also matter more early in titration, when consistency affects tolerability. If you are adjusting doses or recently changed your injection schedule, a telehealth provider should weigh in rather than a social media video, however accurate that video happens to be.